| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 25,494 | 27,177 | ||
| Short-term marketable securities | 317,561 | 292,311 | ||
| Accounts receivable, net of allowances of 1,442 at september 30, 2025 and 1,369 at december 31, 2024 | 32,416 | 36,537 | ||
| Inventory and other deferred costs | 70,793 | 68,385 | ||
| Prepaid expenses and other current assets | 5,761 | 5,716 | ||
| Total current assets | 452,025 | 430,126 | ||
| Property and equipment, net | 26,464 | 25,357 | ||
| Right-of-use leased assets | 16,040 | 16,515 | ||
| Goodwill | 65,945 | 65,945 | ||
| Gross carrying value | 72,213 | - | ||
| Accumulated amortization | 40,502 | - | ||
| Other intangibles, net | 31,711 | 33,152 | ||
| Deferred tax assets | 854 | 1,455 | ||
| Other assets | 5,030 | 5,041 | ||
| Total assets | 598,069 | 577,591 | ||
| Accounts payable | 3,465 | 4,914 | ||
| Accrued expenses | 26,933 | 22,978 | ||
| Acquisition-related obligations | 95 | 95 | ||
| Lease liabilities - short-term | 2,794 | 2,829 | ||
| Total current liabilities | 33,287 | 30,816 | ||
| Convertible senior notes, net | 168,424 | 168,205 | ||
| Lease liabilities - long-term | 14,414 | 14,855 | ||
| Deferred tax liabilities | 2,088 | 95 | ||
| Other long-term liabilities | 933 | 934 | ||
| Total liabilities | 219,146 | 214,905 | ||
| Common stock, 0.01 par value authorized 37,000,000 shares issued 24,291,446 shares at september 30, 2025, and 24,153,165 shares at december 31, 2024 | 243 | 242 | ||
| Additional paid-in capital | 224,145 | 220,822 | ||
| Retained earnings | 173,670 | 160,843 | ||
| Accumulated other comprehensive loss | -2,912 | -2,998 | ||
| Treasury stock, at cost 1,609,942 shares at september 30, 2025 and 1,603,825 shares at december 31, 2024 | 16,223 | 16,223 | ||
| Total stockholders equity | 378,923 | 362,686 | ||
| Total liabilities and stockholders equity | 598,069 | 577,591 | ||
LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT)